Subject
Tool
Region
FOUND 35
This study evaluates the impact of the Common Elements Treatment Approach, a cognitive behavioral therapy intervention, on treatment outcomes for women living with HIV who have experienced intimate partner violence (IPV). While it did not significantly improve HIV treatment retention or viral suppression, participants showed modest overall gains and clear improvements in depression and post-traumatic stress disorder. The article highlights the…
This article examines discrepancies in how causes of death among women living with HIV are recorded. Substance use and mental illness were among the most common contributors to death, yet were rarely documented on death certificates, while HIV/AIDS was frequently listed as a cause of death even when clinicians determined it played a limited role. The authors argue that improving survival among women with HIV requires greater attention to mental…
This study analyzes global trends in HIV/AIDS and other sexually transmitted infections (STIs) among women aged 15–49 using data from the Global Burden of Disease Study 2021. It finds a striking divergence in disease burden: while other STIs account for the majority of infections and prevalent cases, HIV/AIDS remains responsible for most STI-related deaths and disability-adjusted life years (DALYs) among women of reproductive age. The findings…
This report from the United Nations University International Institute for Global Health reviews evidence from low- and middle-income countries on interventions addressing gender inequalities linked to HIV, tuberculosis, and malaria. It finds that the most effective and sustained results come from multi-component approaches that combine HIV services with efforts to transform harmful gender norms, strengthen economic empowerment, expand social…
This UK Parliament Women and Equalities Committee (WEC) report warns that rising HIV diagnoses among women, particularly women exposed through heterosexual sex, require urgent attention in the UK’s HIV Action Plan. While new HIV diagnoses have declined among gay and bisexual men, diagnoses among women increased by 33% between 2019 and 2024, with especially concerning trends among Black African and Asian communities.
This research paper describes the particular vulnerability of women living with HIV in the context of armed conflicts. Disruption to regular testing, treatment regimens, and SRHR services plays a significant role in the worsened health outcomes experienced by WLHIV during conflicts.
Women living with HIV experience disproportionate and alarming rates of coercive practices, mistreatment, and abuse particularly while exercising their sexual and reproductive health and rights. This report seeks to understand women living with HIV's experiences of these human rights violations, highlighting stories from women in over 60 countries, and identifying the persistent and widespread nature of this problem.
This review aims to synthesize existing evidence of the mental health burden on women living with HIV/AIDS in sub-Saharan Africa. It explores the contributing stressors, protective factors, and effects of mental illness on viral suppression rates, providing a clear argument for the integration of increased mental health care services in the HIV response.
This study demonstrated the safety and efficacy of the dapvirine vaginal ring, as well as oral PrEP regimens with tenofovir disoproxil fumarate and emtricitabine, for use during pregnancy. The safety of the oral PrEP methods has previously been established for pregnant cisgender women, but data has been limited for the dapivirine ring. This represents an important step for reducing HIV infection amongst pregnant women, who are three times more…
Lenacapavir, a twice-yearly injectable PrEP medication, was proven to be completely effective in preventing HIV infection in cisgender women. Developed by Gilead Sciences, this is the first HIV prevention drug that resulted in zero new human infections during Phase 3 trials. Lenacapavir holds great promise for the future of HIV prevention, as it represents an alternative that can mitigate challenges of adherence and stigma associated with a…
Misinformation, stigma and discrimination contribute to the promotion of ideas that any type of drug use during pregnancy will result in harm to the foetus. Criminalisation, stigma and discrimination associated with illicit drug use during pregnancy also results in many women keeping their pregnancy concealed and prevents them from accessing a range of services, such as antenatal care, harm reduction services including voluntary drug treatment…
Psychosocial factors were independent atherosclerotic risk factors among Women Living With HIV (WLWH). Research is needed to determine whether interventions for depression and psychosocial stress can mitigate the increased risk of atherosclerosis for WLWH.
This technical guide is intended to support countries in their efforts to increase their capacity to eliminate mother-to-child transmission of HIV in prison, and achieve the ultimate goal of ending AIDS as a public health threat by 2030, “leaving no one behind”.
Despite the importance of women living with HIV (WLHIV) engaging in fertility plan discussions with their healthcare providers (HCPs), little research exists. This study explored perceptions surrounding fertility plan discussions between WLHIV and their HCPs in western Ethiopia, from the perspectives of both women and providers
UNAIDS report on the global AIDS pandemic 2020 shows that women and girls in sub-Saharan Africa continue to be the most affected and accounted for 59% of all new HIV infections in the region in 2019, with 4500 adolescent girls and young women between 15 and 24 years old becoming infected with HIV every week. Young women accounted for 24% of new HIV infections in 2019, despite making up only 10% of the population in sub-Saharan Africa.
In alignment with the United States President’s Emergency Plan for AIDS Relief (PEPFAR) goal to reach ‘95-95-95’ targets – that 95 percent of all people living with HIV will know their status, 95 percent of all those with diagnosed HIV infection will receive sustained antiretroviral therapy (ART), and 95 percent of all those receiving ART will have viral suppression by 2020 – a gender analysis is an important planning tool for the development of…
Communities of people living with HIV across the world refused to accept the slow pace of progress against HIV. Local peer support groups grew into national and international activist movements, demanding their right to the highest attainable standard of health, and to be treated with dignity and respect.
In 2016, 89% of pregnant women living with HIV in Eastern and Southern Africa received antiretroviral treatment to prevent vertical transmission of HIV. Despite this scale-up, in the same region, an estimated 77,000 children (0-14 years) acquired HIV in 2016. AIDS-related illness remains the leading cause of death for women of reproductive age (15-49 years) globally. With countries now providing lifelong treatment to pregnant women living with…
In collaboration with UN Women, the ATHENA Network, AIDS Vaccine Advocacy Coalition (AVAC) and Salamander Trust have undertaken a multistage review of the global status of women’s access to antiretroviral therapy (ART). This global review takes place during a turning point in the HIV epidemic where increasing focus is placed on strategic investments in health. This review is informed by a gender-responsive and human rights-based framework…
This qualitative study examines women's experiences with antiretroviral therapy (ART) adherence and retention in Option B+ care among 39 pregnant and lactating women in Bwaila Hospital, Lilongwe, Malawi. Study participants included 14 in care and 25 out of care women, according to facility records. One of the most important factors influencing adherence and retention was the strength of women’s support systems. In contrast to women in-care, most…